Susquehanna International Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-813,905
Closed -$3.42M 6915
2023
Q1
$3.42M Buy
813,905
+390,801
+92% +$1.64M ﹤0.01% 1387
2022
Q4
$2.54M Sell
423,104
-220,888
-34% -$1.33M ﹤0.01% 1394
2022
Q3
$3.75M Buy
643,992
+411,568
+177% +$2.4M ﹤0.01% 1067
2022
Q2
$1.39M Sell
232,424
-413,120
-64% -$2.47M ﹤0.01% 2087
2022
Q1
$3.02M Sell
645,544
-50,882
-7% -$238K ﹤0.01% 1594
2021
Q4
$1.73M Buy
696,426
+359,633
+107% +$892K ﹤0.01% 2145
2021
Q3
$994K Buy
+336,793
New +$994K ﹤0.01% 2763
2021
Q2
Sell
-263,140
Closed -$766K 6303
2021
Q1
$766K Buy
263,140
+221,941
+539% +$646K ﹤0.01% 3333
2020
Q4
$133K Buy
+41,199
New +$133K ﹤0.01% 4409
2020
Q3
Hold
0
5321
2020
Q2
Hold
0
5393
2020
Q1
Hold
0
5405
2019
Q4
Hold
0
5310
2019
Q3
Hold
0
5370
2019
Q2
Sell
-12,331
Closed -$12K 5371
2019
Q1
$12K Buy
+12,331
New +$12K ﹤0.01% 2880
2018
Q4
Hold
0
5538
2018
Q3
Hold
0
5463
2018
Q2
Sell
-122,884
Closed -$479K 5405
2018
Q1
$479K Buy
122,884
+108,944
+782% +$425K ﹤0.01% 2140
2017
Q4
$37K Buy
+13,940
New +$37K ﹤0.01% 3482
2017
Q3
Sell
-250,636
Closed -$830K 4957
2017
Q2
$830K Buy
+250,636
New +$830K ﹤0.01% 1957
2017
Q1
Sell
-11,818
Closed -$48K 5198
2016
Q4
$48K Buy
+11,818
New +$48K ﹤0.01% 3986
2016
Q3
Sell
-4,377
Closed -$15K 4682
2016
Q2
$15K Buy
4,377
+567
+15% +$1.94K ﹤0.01% 3086
2016
Q1
$20K Sell
3,810
-15,450
-80% -$81.1K ﹤0.01% 3719
2015
Q4
$237K Sell
19,260
-7,352
-28% -$90.5K ﹤0.01% 3617
2015
Q3
$388K Sell
26,612
-14,415
-35% -$210K ﹤0.01% 3314
2015
Q2
$800K Buy
41,027
+8,505
+26% +$166K ﹤0.01% 2907
2015
Q1
$589K Sell
32,522
-2,632
-7% -$47.7K ﹤0.01% 2937
2014
Q4
$830K Buy
+35,154
New +$830K ﹤0.01% 2817
2014
Q3
Sell
-8,140
Closed -$229K 4751
2014
Q2
$229K Buy
8,140
+2,656
+48% +$74.7K ﹤0.01% 3768
2014
Q1
$186K Sell
5,484
-5,048
-48% -$171K ﹤0.01% 3269
2013
Q4
$202K Buy
10,532
+4,024
+62% +$77.2K ﹤0.01% 3536
2013
Q3
$107K Sell
6,508
-11,374
-64% -$187K ﹤0.01% 3283
2013
Q2
$188K Buy
+17,882
New +$188K ﹤0.01% 3196